Mild Cognitive Impairment. Mild cognitive impairment, so stated
Conditions
Interventions
Intervention 1: Intervention group:Cognitive-Behavioral Therapy, Cognitive Behavioral Therapy (CBT), based on the classical cognitive-behavioral approach, will be conducted with the aim of improving t
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
All
Age
60 Years to 80 Years
Inclusion criteria
Inclusion criteria: Receiving a confirmed diagnosis of Mild Cognitive Impairment (MCI) by a neurology specialist. Being between 60 and 80 years of age. Fluency in Persian language and having at least 8 years of formal education. The participant’s ability to attend treatment sessions as scheduled according to the therapeutic protocols and to regularly perform the exercises related to each intervention. The ability to write and fully complete the questions of self-report instruments and computer-based tools across the three stages of implementation.
Exclusion criteria
Exclusion criteria: A confirmed diagnosis of any type of progressive dementia. Having progressive neurological disorders, or a diagnosed cognitive impairment resulting from conditions such as COVID-19 infection, brain injury, stroke, multiple sclerosis (MS), Parkinson’s disease, or other similar causes. Absence from more than four sessions in any of the intervention programs. Exacerbation of symptoms, hospitalization, or undergoing anesthesia and surgery during the implementation of the protocols. Presence of severe visual or hearing impairments, history of stroke, transient ischemic attack (TIA), or head injury with a history of loss of consciousness. History of internal medical conditions such as uncontrolled diabetes, uncontrolled hypertension, uncontrolled hyperlipidemia, obstructive sleep apnea, or a history of HIV infection. Presence of major neurological or psychiatric disorders, including stroke, epilepsy, seizures, Parkinson’s disease, multiple sclerosis (MS), brain injuries, diagnosed schizophrenia, adult attention-deficit/hyperactivity disorder (ADHD), or any condition requiring frequent hospital visits or hospitalizations. Dependence on or abuse of substances or specific medications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Life. Timepoint: Before the intervention – Immediately after the intervention – Three-month follow-up after the intervention. Method of measurement: world health organization- quality of life questionnaire (WHOQOL-100).;Perceived Stress. Timepoint: Before the intervention – Immediately after the intervention – Three-month follow-up after the intervention. Method of measurement: percieved stress scale-14 (PSS-14).;Attention. Timepoint: Before the intervention – Immediately after the intervention – Three-month follow-up after the intervention. Method of measurement: Cambridge Neuropsychological Test Automated Battery (CANTAB) will be used in the subtests of Rapid Visual Information Processing (RVP) and Match to Sample Visual Search (MTS).;Working Memory. Timepoint: Before the intervention – Immediately after the intervention – Three-month follow-up after the intervention. Method of measurement: Cambridge Neuropsychological Test Automated Battery (CANTAB) in the Spatial Working Memory (SWM) subtest. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAnahita Tarki
Islamic Azad University
Outcome results
None listed